Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
160 participants
INTERVENTIONAL
2011-10-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Trial with medicinal product
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Oxytocin on Pair-bonding and Emotion Regulation
NCT02501837
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
NCT07053774
The Role of Oxytocin in the Perception of Faces
NCT02443727
A Randomized Controlled Trial to Test the Effects Oxytocin and Vibration Have on Heat Pain Threshold After UV-B Burn
NCT06651476
Oxytocin for Couples Conflict Resolution
NCT02941692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
nasal spray
Syntocinon (Oxytocin) nasal spray
two-times daily self-administration of nasal spray containing active substance (oxytocin) during five days after wounding.
Placebo
Placebo
two-times daily self-administration of nasal spray containing placebo during five days after wounding.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Syntocinon (Oxytocin) nasal spray
two-times daily self-administration of nasal spray containing active substance (oxytocin) during five days after wounding.
Placebo
two-times daily self-administration of nasal spray containing placebo during five days after wounding.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* in a stable relationship since \> 1 year
Exclusion Criteria
* heavy smoking (\> 5 cigarettes/d)
* extensive skin disease
* artificial UV irradiation during \< 3 months before study inclusion
21 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss National Science Foundation
OTHER
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
01 Studienregister MasterAdmins
Role: STUDY_DIRECTOR
UniversitaetsSpital Zuerich
Severin Laeuchli, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Division of Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Dept. of Dermatology
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Aguilar-Raab C, Stoffel M, Fischer M, Eckstein M, Bodenmann G, Heinrichs M, Ehlert U, Ditzen B. Minimal couple intervention to improve psychobiological stress resilience. Br J Health Psychol. 2025 May;30(2):e12799. doi: 10.1111/bjhp.12799.
Doerr JM, Klaus K, Troxel W, Nater UM, Bodenmann G, Heinrichs M, Ehlert U, Ditzen B. The Effect of Intranasal Oxytocin on the Association Between Couple Interaction and Sleep: A Placebo-Controlled Study. Psychosom Med. 2022 Jul-Aug 01;84(6):727-737. doi: 10.1097/PSY.0000000000001091. Epub 2022 Apr 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH-NR: 2009-0063
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.